ZA978257B - Method of treatment of amyotrophic lateral sclerosis. - Google Patents
Method of treatment of amyotrophic lateral sclerosis.Info
- Publication number
- ZA978257B ZA978257B ZA9708257A ZA978257A ZA978257B ZA 978257 B ZA978257 B ZA 978257B ZA 9708257 A ZA9708257 A ZA 9708257A ZA 978257 A ZA978257 A ZA 978257A ZA 978257 B ZA978257 B ZA 978257B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- lateral sclerosis
- amyotrophic lateral
- amyotrophic
- sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9611186A FR2753379B1 (fr) | 1996-09-13 | 1996-09-13 | Methode de traitement de la sclerose laterale amyotrophique |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA978257B true ZA978257B (en) | 1998-03-24 |
Family
ID=9495715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9708257A ZA978257B (en) | 1996-09-13 | 1997-09-12 | Method of treatment of amyotrophic lateral sclerosis. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6723315B1 (fr) |
EP (1) | EP0929671A1 (fr) |
JP (1) | JP2001504088A (fr) |
KR (1) | KR20010029506A (fr) |
CN (1) | CN1155706C (fr) |
AU (1) | AU740641B2 (fr) |
BR (1) | BR9711955A (fr) |
CA (1) | CA2259283A1 (fr) |
CZ (1) | CZ84799A3 (fr) |
FR (1) | FR2753379B1 (fr) |
HU (1) | HUP9903779A3 (fr) |
IL (1) | IL128185A0 (fr) |
NO (1) | NO991158D0 (fr) |
SK (1) | SK31899A3 (fr) |
WO (1) | WO1998011213A1 (fr) |
ZA (1) | ZA978257B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ533833A (en) * | 2001-12-21 | 2008-01-31 | Salk Inst For Biological Studi | Targeted retrograde gene delivery to motor neurons |
US20070049630A1 (en) * | 2005-08-24 | 2007-03-01 | Allergan, Inc. | Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis |
EP2323691A2 (fr) * | 2008-07-11 | 2011-05-25 | Glaxo Group Limited | Traitement de la sclerose laterale amyotrophique avec nogo-a-antagoniste |
JP2015529685A (ja) | 2012-09-17 | 2015-10-08 | ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルThe Research Institute Atnationwide Children’S Hospital | 筋萎縮性側索硬化症の処置のための組成物および方法 |
EP3065784A4 (fr) | 2013-11-05 | 2017-05-10 | The Research Institute at Nationwide Children's Hospital | Compositions et procédés d'inhibition de nf-kb et sod-1 afin de traiter la sclérose latérale amyotrophique |
EP4008356A1 (fr) * | 2016-03-31 | 2022-06-08 | University of Cincinnati | Procédés et compositions pour le traitement de la sla |
US20210177989A1 (en) * | 2018-08-30 | 2021-06-17 | Rowan University | Methods of Treating or Preventing Amyotrophic Lateral Sclerosis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
JPH08501686A (ja) * | 1992-09-25 | 1996-02-27 | ローン−プーラン・ロレ・ソシエテ・アノニム | 中枢神経系、特に脳における細胞への外来遺伝子の転移のためのアデノウィルスベクター |
FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
FR2717824B1 (fr) * | 1994-03-25 | 1996-04-26 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
FR2724945B1 (fr) | 1994-09-27 | 1996-12-27 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en therapie genique |
JP2002515816A (ja) | 1997-06-30 | 2002-05-28 | アバンテイス・フアルマ・エス・アー | in vivo組織に核酸ベクターを最適に電気導入する装置 |
-
1996
- 1996-09-13 FR FR9611186A patent/FR2753379B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-10 CN CNB971964149A patent/CN1155706C/zh not_active Expired - Fee Related
- 1997-09-10 HU HU9903779A patent/HUP9903779A3/hu unknown
- 1997-09-10 CZ CZ99847A patent/CZ84799A3/cs unknown
- 1997-09-10 WO PCT/FR1997/001589 patent/WO1998011213A1/fr not_active Application Discontinuation
- 1997-09-10 JP JP51330998A patent/JP2001504088A/ja active Pending
- 1997-09-10 CA CA002259283A patent/CA2259283A1/fr not_active Abandoned
- 1997-09-10 IL IL12818597A patent/IL128185A0/xx unknown
- 1997-09-10 EP EP97940204A patent/EP0929671A1/fr not_active Withdrawn
- 1997-09-10 KR KR1019997002112A patent/KR20010029506A/ko not_active Application Discontinuation
- 1997-09-10 BR BR9711955A patent/BR9711955A/pt unknown
- 1997-09-10 AU AU42125/97A patent/AU740641B2/en not_active Ceased
- 1997-09-10 SK SK318-99A patent/SK31899A3/sk unknown
- 1997-09-10 US US09/254,617 patent/US6723315B1/en not_active Expired - Fee Related
- 1997-09-12 ZA ZA9708257A patent/ZA978257B/xx unknown
-
1999
- 1999-03-10 NO NO991158A patent/NO991158D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1998011213A1 (fr) | 1998-03-19 |
KR20010029506A (ko) | 2001-04-06 |
SK31899A3 (en) | 1999-10-08 |
HUP9903779A3 (en) | 2002-01-28 |
CN1155706C (zh) | 2004-06-30 |
NO991158L (no) | 1999-03-10 |
HUP9903779A2 (hu) | 2000-03-28 |
US6723315B1 (en) | 2004-04-20 |
CA2259283A1 (fr) | 1998-03-19 |
AU740641B2 (en) | 2001-11-08 |
EP0929671A1 (fr) | 1999-07-21 |
IL128185A0 (en) | 1999-11-30 |
BR9711955A (pt) | 1999-08-24 |
AU4212597A (en) | 1998-04-02 |
JP2001504088A (ja) | 2001-03-27 |
CN1225131A (zh) | 1999-08-04 |
FR2753379A1 (fr) | 1998-03-20 |
NO991158D0 (no) | 1999-03-10 |
CZ84799A3 (cs) | 1999-06-16 |
FR2753379B1 (fr) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA977564B (en) | Method of treatment | |
ZA986363B (en) | Novel method of treatment. | |
ZA985237B (en) | Novel method of treatment. | |
GB9605828D0 (en) | Treatment method | |
ZA978257B (en) | Method of treatment of amyotrophic lateral sclerosis. | |
ZA986364B (en) | Novel method of treatment. | |
ZA974421B (en) | Method of improving skin condition. | |
AU7204996A (en) | Method for treating amyotrophic lateral sclerosis | |
ZA986365B (en) | Novel method of treatment. | |
ZA965346B (en) | Methods of treating neuropeptide Y-associated conditions. | |
ZA977867B (en) | Method of treatment. | |
ZA973988B (en) | Method of treatment | |
EP0682034A3 (fr) | Procédé de préparation de cyanoalkylorganooxysilanes de cyanoalkylchlorosilanes. | |
GB9714841D0 (en) | Treatment method | |
ZA200007396B (en) | Method of treatment. | |
AP2005003432A0 (en) | Novel method of treatment. | |
ZA978139B (en) | Process for the biological-thermal treatment of waste. | |
GB9407335D0 (en) | Method of treatment | |
ZA985238B (en) | Novel method of treatment. | |
ZA985235B (en) | Novel method of treatment. | |
ZA985236B (en) | Novel method of treatment. | |
ZA963472B (en) | Method of treatment. | |
GB9414652D0 (en) | Method of treatment | |
ZA965345B (en) | Methods of treating neuropeptide Y-associated conditions. | |
GB9600888D0 (en) | Method of treatment |